TP53 mutations and survival in squamous-cell carcinoma of the head and neck

New England Journal of Medicine

Volumn 357, Issue 25, 2007, Pages 2552-2561

  Poeta, M Luana ^a,c   Manola, Judith ^d   Goldwasser, Meredith A ^d   Forastiere, Arlene ^a   Benoit, Nicole ^a   Califano, Joseph A ^a   Ridge, John A ^e   Goodwin, Jarrard ^f   Kenady, Daniel ^g   Saunders, John ^b   Westra, William ^a   Sidransky, David ^a   Koch, Wayne M ^a,h  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CRYSTAL STRUCTURE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA PROTEIN COMPLEX; FEMALE; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

EID: 37349055876     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa073770     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002;21:7435-51.
3. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:712-7.
4. Boffetta P, Mashberg A, Winkelmann R, Garfinkel L. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx. Int J Cancer 1992;52:530-3.
5. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998;82:1367-75.
6. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31.
7. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32:Suppl 1:S59-S66.
8. Olshan AF, Weissler MC, Pei H, Conway K. p53 Mutations in head and neck cancer: new data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev 1997;6:499-504.
9. González MV, Pello MF, López-Larrea C, Suárez C, Menéndez MJ, Coto E. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res 1995;1:1043-9.
10. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
11. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
12. Guimaraes DP, Hainaut P. TP53: a key gene in human cancer. Biochimie 2002;84:83-93.
13. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol 2003;39:222-31.
14. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003;116:4077-85.
15. Giono LE, Manfredi JJ. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 2006;209:13-20.
16. Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000;12:229-39.
17. Bradford CR. Predictive factors in head and neck cancer. Hematol Oncol Clin North Am 1999;13:777-85.
18. Soussi T, Béroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-40.
19. Soussi T, Ishioka C, Claustres M, Béroud C. Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer 2006;6:83-90.
20. Taylor D, Koch WM, Zahurak M, Shah K, Sidransky D, Westra WH. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol 1999;30:1221-5.
21. Sjögren S, Inganäs M, Norberg T, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
22. Ahrendt SA, Halachmi S, Chow JT, et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A 1999;96:7382-7.
23. Friend S. p53: A glimpse at the puppet behind the shadow play. Science 1994;265:334-5.
24. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994;265:346-55.
25. Børresen AL, Andersen TI, Eyfjörd JE, et al. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer 1995;14:71-5.
26. Erber R, Conradt C, Homann N, et al. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 1998;16:1671-9.
27. Wikman FP, Lu ML, Thykjaer T, et al. Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin Chem 2000;46:1555-61.
28. Frontiers in bioscience: database: amino acids. (Accessed November 21, 2007, at http://www.bioscience.org/urllists/aminacid.htm.)
29. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
30. Peto R, Peto J. Asymptotically efficient rank invariate test procedures. J R Stat Soc [A] 1972;135:185-206.
31. Cox DR. Analysis of binary data. London: Methuen, 1970.
32. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 1984;40:819-25.
33. Cox DR. Regression models and lifetables. J R Stat Soc [B] 1972;34:187-220.
34. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974;19:716-23.
35. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
36. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
37. Soussi T, Kato S, Levy PP, Ishioka C. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 2005;25:6-17.